Ebola virus screening during pregnancy in West Africa: unintended consequences

被引:9
|
作者
Deaver, John E. [1 ,2 ]
Cohen, Wayne R. [3 ]
机构
[1] Asociac Siempre Salud, Chincha, Peru
[2] Bayhlth Milford Mem Hosp, Dept Obstet & Gynecol, Milford, DE USA
[3] Univ Arizona, Coll Med, Dept Obstet & Gynecol, Tucson, AZ USA
关键词
Africa; Ebola; false-positive reactions; hemorrhagic fever; mass screening; predictive value of tests; pregnancy; HEMORRHAGIC-FEVER; EPIDEMIOLOGY; DISEASE; MANAGEMENT; BURDEN; TRENDS;
D O I
10.1515/jpm-2015-0118
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: We hypothesized that predictive value of traditional Ebola virus disease (EVD) screening in West African pregnant women is low because febrile and hemorrhagic complications of pregnancy that can mimic EVD are common. Methods: Proportions of various categories of pregnancy loss from a hypothetical cohort of West African gravidas were used to construct a Kaplan-Meier curve. The incidence rate of each category was determined by multiplying its proportion by the overall incidence rate, calculated from the inverse of the area under the curve. Incidence rates of Ebola-like illnesses during pregnancy were obtained by multiplying their percentages by the incidence rates of categories of loss with which they coincide. Results: During pregnancy about 1.5% of suspected EVD cases would prove to have EVD. Most of the remaining 98.5% would have hemorrhagic and febrile complications of pregnancy. Conclusion: Current guidelines consider obstetrical interventions inappropriate in suspected EVD during pregnancy. However, because the overwhelming majority of cases suspected by screening do not have EVD and might benefit from obstetrical intervention, policy makers must consider whether the small risk to properly protected health care workers from the 1.5% with true EVD justifies withholding potentially life-saving care from the 98.5% who ultimately test negative for EVD.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 50 条
  • [1] Viral Infections in Pregnancy: A Focus on Ebola Virus
    Olgun, Nicole S.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (09) : 993 - 998
  • [2] Containing Ebola virus infection in West Africa
    Kucharski, J.
    Piot, P.
    EUROSURVEILLANCE, 2014, 19 (36) : 2 - 4
  • [3] Insights from clinical research completed during the west Africa Ebola virus disease epidemic
    Rojek, Amanda
    Horby, Peter
    Dunning, Jake
    LANCET INFECTIOUS DISEASES, 2017, 17 (09) : E280 - E292
  • [4] Ebola Outbreak in West Africa; Is Selenium Involved?
    Abd-ElMoemen, Nouran
    Menshawy, Ahmed
    Negida, Ahmed
    El-Din, Marwa Alaa
    Kamel, Ahmed
    Farouk, Alaa Ehab
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2016, 22 (01) : 135 - 141
  • [5] The 2014 Ebola virus disease outbreak in West Africa
    Gatherer, Derek
    JOURNAL OF GENERAL VIROLOGY, 2014, 95 : 1619 - 1624
  • [6] Satellites and the New War on Infection: Tracking Ebola in West Africa
    Peckham, Robert
    Sinha, Ria
    GEOFORUM, 2017, 80 : 24 - 38
  • [7] Ebola Virus Disease and Pregnancy: A Review of the Current Knowledge of Ebola Virus Pathogenesis, Maternal, and Neonatal Outcomes
    Bebell, Lisa M.
    Oduyebo, Titilope
    Riley, Laura E.
    BIRTH DEFECTS RESEARCH, 2017, 109 (05): : 353 - 362
  • [8] Modeling spatial invasion of Ebola in West Africa
    D'Silva, Jeremy P.
    Eisenberg, Marisa C.
    JOURNAL OF THEORETICAL BIOLOGY, 2017, 428 : 65 - 75
  • [9] Community-based care of Ebola virus disease in west Africa
    Salmon, Sharon
    McLaws, Mary-Louise
    Fisher, Dale
    LANCET INFECTIOUS DISEASES, 2015, 15 (02) : 151 - 152
  • [10] Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga
    Chippaux, Jean-Philippe
    JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2014, 20